Plasma kallistatin levels in patients with severe community-acquired pneumonia

INTRODUCTION: Community-acquired pneumonia (CAP) requiring intensive care unit (ICU) treatment commonly causes acute respiratory failure with high mortality. Kallistatin, an endogenous tissue kallikrein inhibitor, has been reported to be protective in various human diseases. The aim of this study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wei-Chieh, Lu, Shiou-Ling, Lin, Chiou-Feng, Chen, Chang-Wen, Chao, Lee, Chao, Julie, Lin, Yee-Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056893/
https://www.ncbi.nlm.nih.gov/pubmed/23394256
http://dx.doi.org/10.1186/cc12507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056893/
https://www.ncbi.nlm.nih.gov/pubmed/23394256
http://dx.doi.org/10.1186/cc12507

Ejemplares similares